For the evaluation of patients with suspected CAD, the costs of single-photo emission CT were significantly lower than that of PET or coronary CTA, according to new data from the SPARC registry.  At 2 years, patients who underwent PET had higher costs and mortality compared with SPECT, and patients who underwent coronary CTA had higher costs and similar mortality compared with SPECT, researchers reported.

Read more here.